Jul 14, 2026
NextCure (NXTC) Stock Skyrockets 300% Following $320 Million Avere Therapeutics Merger Agreement
NextCure (NXTC) stock exploded 300% on a $320M merger announcement with Avere Therapeutics. The combined company will trade as AVRX on Nasdaq.
The post NextCure (NXTC) Stock Skyrockets 300% Following $320 Million Avere Therapeutics Merger Agreement appeared first on Blockonomi.
Source: Blockonomi →Related News
- 3 minutes ago
Meta Platforms Inc (META) Stock: Faces $942 Million Liability After Landmark Chi...
- 13 minutes ago
Top Dividend Stocks to Buy and Hold: Chevron (CVX), Johnson & Johnson (JNJ), and...
- 13 minutes ago
Ondas Holdings (ONDS) Stock Climbs on Jacksonville Jaguars Counter-Drone Deal
- 15 minutes ago
CoStar Group (CSGP) Stock: U.S. Office Vacancy Set to Hold Steady Through 2026
- 20 minutes ago
Microsoft (MSFT) Stock Surges Nearly 30% as Cash Position Strengthens Amid Compe...